168 related articles for article (PubMed ID: 36304920)
1. Editorial: Bioactive sphingolipids in health and disease.
Aslan M; Oztas Y; Silva LC
Front Mol Biosci; 2022; 9():1051449. PubMed ID: 36304920
[No Abstract] [Full Text] [Related]
2. Reduction of ceramide de novo synthesis in solid tissues changes sphingolipid levels in rat plasma, erythrocytes and platelets.
Błachnio-Zabielska A; Baranowski M; Wójcik B; Górski J
Adv Med Sci; 2016 Mar; 61(1):72-7. PubMed ID: 26521206
[TBL] [Abstract][Full Text] [Related]
3. Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.
Nikolova-Karakashian MN; Reid MB
Antioxid Redox Signal; 2011 Nov; 15(9):2501-17. PubMed ID: 21453197
[TBL] [Abstract][Full Text] [Related]
4. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
5. Sphingolipid Profiling Reveals Different Extent of Ceramide Accumulation in Bovine Retroperitoneal and Subcutaneous Adipose Tissues.
Leung YH; Christiane Bäßler S; Koch C; Scheu T; Meyer U; Dänicke S; Huber K; Kenéz Á
Metabolites; 2020 Nov; 10(11):. PubMed ID: 33228142
[TBL] [Abstract][Full Text] [Related]
6. Novel agents targeting bioactive sphingolipids for the treatment of cancer.
Adan-Gokbulut A; Kartal-Yandim M; Iskender G; Baran Y
Curr Med Chem; 2013; 20(1):108-22. PubMed ID: 23244584
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic applications of bioactive sphingolipids in hematological malignancies.
Ekiz HA; Baran Y
Int J Cancer; 2010 Oct; 127(7):1497-506. PubMed ID: 20503271
[TBL] [Abstract][Full Text] [Related]
8. An overview of sphingolipid metabolism: from synthesis to breakdown.
Gault CR; Obeid LM; Hannun YA
Adv Exp Med Biol; 2010; 688():1-23. PubMed ID: 20919643
[TBL] [Abstract][Full Text] [Related]
9. The role of sphingolipids in the maintenance of fibroblast morphology. The inhibition of protrusional activity, cell spreading, and cytokinesis induced by fumonisin B1 can be reversed by ganglioside GM3.
Meivar-Levy I; Sabanay H; Bershadsky AD; Futerman AH
J Biol Chem; 1997 Jan; 272(3):1558-64. PubMed ID: 8999828
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
[TBL] [Abstract][Full Text] [Related]
11. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
12. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
13. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
14. Trafficking and Functions of Bioactive Sphingolipids: Lessons from Cells and Model Membranes.
Zhou K; Blom T
Lipid Insights; 2015; 8(Suppl 1):11-20. PubMed ID: 26715852
[TBL] [Abstract][Full Text] [Related]
15. [Sphingolipid-mediated apoptotic signaling pathways].
Cuvillier O; Andrieu-Abadie N; Ségui B; Malagarie-Cazenave S; Tardy C; Bonhoure E; Levade T
J Soc Biol; 2003; 197(3):217-21. PubMed ID: 14708343
[TBL] [Abstract][Full Text] [Related]
16. Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases.
Custodia A; Romaus-Sanjurjo D; Aramburu-Núñez M; Álvarez-Rafael D; Vázquez-Vázquez L; Camino-Castiñeiras J; Leira Y; Pías-Peleteiro JM; Aldrey JM; Sobrino T; Ouro A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897658
[TBL] [Abstract][Full Text] [Related]
17. A novel glycosphingolipid hydrolyzing enzyme, glycosphingolipid ceramide deacylase, which cleaves the linkage between the fatty acid and sphingosine base in glycosphingolipids.
Hirabayashi Y; Kimura M; Matsumoto M; Yamamoto K; Kadowaki S; Tochikura T
J Biochem; 1988 Jan; 103(1):1-4. PubMed ID: 3360750
[TBL] [Abstract][Full Text] [Related]
18. Effect of atrial pacing on the level of bioactive sphingolipids in the heart ventricles of the rat.
Wojcik B; Baranowski M; Chabowski A; Gorski J
J Physiol Pharmacol; 2015 Jun; 66(3):385-9. PubMed ID: 26084220
[TBL] [Abstract][Full Text] [Related]
19. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
[TBL] [Abstract][Full Text] [Related]
20. Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis.
Mignard V; Dubois N; Lanoé D; Joalland MP; Oliver L; Pecqueur C; Heymann D; Paris F; Vallette FM; Lalier L
J Lipid Res; 2020 Jul; 61(7):1025-1037. PubMed ID: 32350079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
